Management of temporomandibular disorder through self-monitoring application use and cognitive behavioral therapy for temporomandibular disorder patients and evaluation of symptom improvement effect : Pilot study

Seoul National University Bundang Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新: 2023年11月13日

适应症

试验速览

暂无简介。

•? Adults aged 19 to 65 years old.
•? Patients diagnosed with temporomandibular disorder (TMD) who visited the Seoul National University Dental Hospital.
•? Patients diagnosed with muscular disorders, temporomandibular joint internal derangements, and temporomandibular joint arthritis based on clinical and radiological examinations.
•? Individuals who voluntarily decided to participate in this clinical trial and provided written consent.

•? Individuals not diagnosed with temporomandibular disorder (TMD) based on clinical and radiological examinations.
•? Individuals with intrinsic diseases of the temporomandibular joint: ankylosis, tumors.
•? Individuals with traumatic conditions of the temporomandibular joint: mandibular condyle fractures, major facial trauma (e.g., from traffic accidents, assaults, etc.).
•? Individuals suffering from rare muscular diseases such as severe myasthenia gravis, Eaton-Lambert syndrome, and amyotrophic lateral sclerosis.
•? Individuals with serious metabolic diseases like severe hypertension or diabetes.
•? Individuals diagnosed with neurological disorders (e.g., Parkinson's, Alzheimer's) or psychiatric disorders.
•? Individuals currently taking medications for sleep disorders (e.g., benzodiazepines, muscle relaxants, tricyclic antidepressants, etc.), or potentially consuming unauthorized drugs, alcohol, or narcotics.
•? Individuals undergoing dental orthodontics or wearing other oral devices.
•? Cases where the participant withdraws their consent.
•? Any other individuals deemed inappropriate for the study by the principal investigator.

发起方